237 related articles for article (PubMed ID: 31439870)
1. Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.
Lee HE; Lee JY; Yang G; Kang HC; Cho YY; Lee HS; Lee JY
Sci Rep; 2019 Aug; 9(1):12277. PubMed ID: 31439870
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome.
Ahmad I; Muneer KM; Tamimi IA; Chang ME; Ata MO; Yusuf N
Toxicol Appl Pharmacol; 2013 Jul; 270(1):70-6. PubMed ID: 23583630
[TBL] [Abstract][Full Text] [Related]
4. The Beta-Hydroxybutyrate Suppresses the Migration of Glioma Cells by Inhibition of NLRP3 Inflammasome.
Shang S; Wang L; Zhang Y; Lu H; Lu X
Cell Mol Neurobiol; 2018 Nov; 38(8):1479-1489. PubMed ID: 30218403
[TBL] [Abstract][Full Text] [Related]
5. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 inflammasomes in macrophages drive colorectal cancer metastasis to the liver.
Deng Q; Geng Y; Zhao L; Li R; Zhang Z; Li K; Liang R; Shao X; Huang M; Zuo D; Wu Y; Ma Q
Cancer Lett; 2019 Feb; 442():21-30. PubMed ID: 30392787
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by
Li LH; Lin JS; Chiu HW; Lin WY; Ju TC; Chen FH; Chernikov OV; Liu ML; Chang JC; Hsu CH; Chen A; Ka SM; Gao HW; Hua KF
Front Immunol; 2019; 10():1815. PubMed ID: 31417575
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
9. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.
Yeon SH; Yang G; Lee HE; Lee JY
J Leukoc Biol; 2017 Jan; 101(1):205-215. PubMed ID: 27256568
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 Inflammasome Activation in MΦs-CRC Crosstalk Promotes Colorectal Cancer Metastasis.
Zhang L; Wang Y; Liu X; Zhang Y
Ann Clin Lab Sci; 2022 Jul; 52(4):571-579. PubMed ID: 36197770
[TBL] [Abstract][Full Text] [Related]
11. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome activation in murine macrophages caused by Neospora caninum infection.
Wang X; Gong P; Zhang X; Wang J; Tai L; Wang X; Wei Z; Yang Y; Yang Z; Li J; Zhang X
Parasit Vectors; 2017 May; 10(1):266. PubMed ID: 28558839
[TBL] [Abstract][Full Text] [Related]
13. β
Hofbauer D; Mougiakakos D; Broggini L; Zaiss M; Büttner-Herold M; Bach C; Spriewald B; Neumann F; Bisht S; Nolting J; Zeiser R; Hamarsheh S; Eberhardt M; Vera J; Visentin C; De Luca CMG; Moda F; Haskamp S; Flamann C; Böttcher M; Bitterer K; Völkl S; Mackensen A; Ricagno S; Bruns H
Immunity; 2021 Aug; 54(8):1772-1787.e9. PubMed ID: 34289378
[TBL] [Abstract][Full Text] [Related]
14. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
15. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against
Paroli AF; Gonzalez PV; Díaz-Luján C; Onofrio LI; Arocena A; Cano RC; Carrera-Silva EA; Gea S
Front Immunol; 2018; 9():913. PubMed ID: 29774028
[TBL] [Abstract][Full Text] [Related]
17. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin L3 From
Celias DP; Corvo I; Silvane L; Tort JF; Chiapello LS; Fresno M; Arranz A; Motrán CC; Cervi L
Front Immunol; 2019; 10():552. PubMed ID: 30967874
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer.
Ju M; Bi J; Wei Q; Jiang L; Guan Q; Zhang M; Song X; Chen T; Fan J; Li X; Wei M; Zhao L
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33212483
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]